Bill > H0021

This bill: - Requires certain registered practitioners to complete a 2-hour continuing education course on prescribing controlled substances as part of their biennial license renewal. - Directs the applicable boards to adopt rules establishing guidelines for prescribing controlled substances for acute pain, including evaluation of the patient, creation and maintenance of a treatment plan, and obtaining informed consent. - Limits prescriptions for opioid drugs listed as Schedule II controlled substances to a 3-day supply for the treatment of acute pain, with exceptions allowing up to a 7-day supply in certain circumstances. - Requires prescribers to indicate "NONACUTE PAIN" on prescriptions for opioid drugs listed as Schedule II controlled substances for the treatment of pain other than acute pain. - Requires prescribers who prescribe a Schedule II controlled substance for the treatment of pain related to a traumatic injury with an Injury Severity Score of 9 or greater to concurrently prescribe an emergency opioid antagonist. - Establishes a prescription drug monitoring program to collect and store information on dispensed controlled substances, and provides access to the information to certain entities. - Makes various other changes related to the regulation of controlled substances, pharmacists, and pain management clinics. - Appropriates funds to address the opioid crisis, including for treatment services, emergency opioid antagonists, and improvements to the prescription drug monitoring program.

Budget and Finance, Health and Social Services

Health and Human Services Committee (H), Health Quality Subcommittee (H)

http://www.flsenate.gov/Session/Bill/2018/21